Hierarchical joint analysis of marginal summary statistics — Part I: Multipopulation fine mapping and credible set construction
Genetic Epidemiology · 2024
DOI: 10.1002/gepi.22562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Epidemiology, 2024. Verfasst von Jiayi Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Public Health Sciences, Division of Biostatistics, Keck School of Medicine, University of Southern California, Los Angel…. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Polymorphism, Single Nucleotide, Linkage Disequilibrium, Bayes Theorem. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
Recent advancement in genome‐wide association studies (GWAS) comes from not only increasingly larger sample sizes but also the shift in focus towards underrepresented populations. Multipopulation GWAS increase power to detect novel risk variants and improve fine‐mapping resolution by leveraging evidence and differences in linkage disequilibrium (LD) from diverse populations. Here, we expand upon our previous approach for single‐population fine‐mapping through Joint Analysis of Marginal SNP Effects (JAM) to a multipopulation analysis (mJAM). Under the assumption that true causal variants are common across studies, we implement a hierarchical model framework that conditions on multiple SNPs while explicitly incorporating the different LD structures across populations. The mJAM framework can be used to first select index variants using the mJAM likelihood with different feature selection approaches. In addition, we present a novel approach leveraging the ideas of mediation to construct credible sets for these index variants. Construction of such credible sets can be performed given any existing index variants. We illustrate the implementation of the mJAM likelihood through two implementations: mJAM‐SuSiE (a Bayesian approach) and mJAM‐Forward selection. Through simulation studies based on realistic effect sizes and levels of LD, we demonstrated that mJAM performs well for constructing concise credible sets that include the underlying causal variants. In real data examples taken from the most recent multipopulation prostate cancer GWAS, we showed several practical advantages of mJAM over other existing multipopulation methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population and Public Health Sciences, Division of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Department of Population and Public Health Science, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
- Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Jiayi Shen
Förderung
- NCI NIH HHS
- NHGRI NIH HHS
- National Human Genome Research Institute
Zitieren
APA
Shen, J., Jiang, L., Wang, K., Wang, A., Chen, F., Newcombe, P. J., Haiman, C. A., & Conti, D. V. (2024). Hierarchical joint analysis of marginal summary statistics — Part I: Multipopulation fine mapping and credible set construction. Genetic Epidemiology. https://doi.org/10.1002/gepi.22562
Vancouver
Shen J, Jiang L, Wang K, Wang A, Chen F, Newcombe PJ, et al. Hierarchical joint analysis of marginal summary statistics — Part I: Multipopulation fine mapping and credible set construction. Genetic Epidemiology. 2024. doi:10.1002/gepi.22562
BibTeX
@article{Shen2024,
author = {Shen, Jiayi and Jiang, Lai and Wang, Kan and Wang, Anqi and Chen, Fei and Newcombe, Paul J and Haiman, Christopher A and Conti, David V},
title = {Hierarchical joint analysis of marginal summary statistics — Part I: Multipopulation fine mapping and credible set construction},
journal = {Genetic Epidemiology},
year = {2024},
doi = {10.1002/gepi.22562}
}
EUVIMED